德国拜耳公司研制的新一代降血脂药物西立伐他汀 (商品名拜斯亭 )被国家药品监督管理局批准为进口一类新药 ,日前在中国上市。西立伐他汀是第 3代他汀类降脂药物 ,其降脂效力是其他同类产品的 10 0～ 30 0倍 ,而常用剂量仅为它们的 1/10 0～ 1/2 0 0 ,从而大大减少了毒副作用。 German Bayer company developed a new generation of hypolipidemic drug livastatin (trade name Baisite Ting) by the State Drug Administration approved the import of a new class of drugs, recently listed in China. Cerivastatin is the third generation of statins lipid-lowering drugs, the lipid-lowering potency of other similar products 10 ~ 30 0 times, and the commonly used dose of only their 1/10 0 ~ 1/2 0 0, which greatly Reduce the toxic side effects.